A0189
Amyloid β Protein Fragment 1-38
≥95% (HPLC), powder
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
0.5 MG
691,00 €
691,00 €
Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.
A propos de cet article
Formule empirique (notation de Hill) :
C184H277N51O56S
Numéro CAS:
Poids moléculaire :
4131.54
UNSPSC Code:
12352202
NACRES:
NA.77
MDL number:
Passer à
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider1 of 4
Cet article | A4848 | A1472 | A7973 |
|---|---|---|---|
| form powder | form lyophilized powder | form powder | form lyophilized powder |
| assay ≥95% (HPLC) | assay ≥87% (HPLC) | assay ≥90% (HPLC) | assay ≥80% (HPLC) |
| Quality Level 200 | Quality Level 200 | Quality Level 100 | Quality Level 200 |
| storage temp. −20°C | storage temp. −20°C | storage temp. −20°C | storage temp. −20°C |
| solubility H2O: 1 mg/mL | solubility H2O: soluble | solubility - | solubility H2O: soluble |
| color white | color - | color - | color - |
![MCA-[Asn670, Leu671]-Amyloid β/A4 Precursor Protein 770 Fragment 667-676-DNP-Lys-Arg-Arg-NH2 ≥90% (HPLC)](/deepweb/assets/sigmaaldrich/product/images/375/511/f63f11a7-86de-45c4-95a0-7afa616bb265/640/f63f11a7-86de-45c4-95a0-7afa616bb265.jpg)
![[Arg13] Amyloid-β-Protein Fragment 1-40 ≥80% (HPLC), lyophilized powder](/deepweb/assets/sigmaaldrich/product/images/132/249/f6ab5ff8-bec9-4c18-b8b8-7b6bc8f9d58e/640/f6ab5ff8-bec9-4c18-b8b8-7b6bc8f9d58e.jpg)
Biochem/physiol Actions
β-Amyloid peptide that forms cross-β-sheet fibrils of 70-90 Å diameter with similar antigenicity as those found in Alzheimer′s disease.
Classe de stockage
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
P E Fraser et al.
Journal of neuroscience research, 28(4), 474-485 (1991-04-01)
To elucidate the relationship between amyloid fibril formation in Alzheimer disease (AD) and the primary structure of the beta-amyloid protein (beta-AP), we investigated the ability of peptides sharing sequences with beta-AP to form fibrils in vitro and to recognize anti-beta-amyloid
P E Gottschall
Neuroreport, 7(18), 3077-3080 (1996-11-25)
Since administration of anti-inflammatory drugs has been reported to possibly slow the progression of Alzheimer's disease, an effort was made to define effector functions induced by beta-amyloid (A beta) which may be inhibited by these drugs. Rat microglia in culture
M P Mattson et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 12(2), 376-389 (1992-02-01)
In Alzheimer's disease (AD), abnormal accumulations of beta-amyloid are present in the brain and degenerating neurons exhibit cytoskeletal aberrations (neurofibrillary tangles). Roles for beta-amyloid in the neuronal degeneration of AD have been suggested based on recent data obtained in rodent
Active Filters
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique